T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
The competent immune system controls disease effectively due to induction, function, and regulation of effector lymphocytes. Immunosurveillance is exerted mostly by cytotoxic T-lymphocytes (CTLs) while specific immune suppression is associated with tumor malignancy and progression. In squamous cell...
Saved in:
Main Authors: | A. E. Albers, L. Strauss, T. Liao, T. K. Hoffmann, A. M. Kaufmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/236378 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
by: Yidan Shan, et al.
Published: (2025-01-01) -
Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy
by: Saravanan Sekaran, et al.
Published: (2024-06-01) -
Virotherapy in Head and Neck Cancer
by: Zhan Wang
Published: (2024-03-01) -
Screening of head neck cancer
by: Shrikant B. Mali
Published: (2024-03-01) -
Financial toxicity in head and neck cancer care: Current issues and future directions
by: Amol S. Dhane
Published: (2024-09-01)